Blog
New clinical trial regulation provides positive outlook for EU
In a recent article on Outsourcing Pharma, Dan Stanton discusses the new EU clinical trial regulation and it’s intention to simplify the approval process in hopes of making the EU more accessible and desirable for clinical research. The new regulation will take action...
Pearl Pathways opens second location in Texas
Pearl Pathways announces the addition of a second location in College Station, Texas. Through the support of the Research Valley Partnership and its Research Valley Innovation Center, Pearl Pathways has the unique opportunity of expanding into a new market. Diana...
Inclusion of women in clinical research still too small
The Government Accountability Office (GAO) recently released a report in regard to women in clinical research. While past efforts by the National Institutes of Health (NIH) have increased the number of women involved in research, further changes are still necessary....
Wearable technology and clinical trials: beneficial or problematic?
Wearable technology has been taking over the consumer world for health and fitness, and speculation has grown around the topic of utilizing the devices in clinical trials. First Post Business addressed the idea, along with input from Michael Shanler, research director...
HHS investigates FDA in 2016
According to Zachary Brennan of RAPS, The U.S. Department of Health and Human Services Inspector General will be investigating FDA on post-marketing requirements, supply chain exchanges, hospital medical device oversight, and three additional programs on food and...